Tags : Astellas Pharma

Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

The increasing cases of autoimmune disorders such as rheumatoid arthritis are driving the growth of immunology products in the global market. Multiple companies have been focusing on Oncology, Hematology and multiple diseases but due to a drastic increase in the immune disorders, Immunology segment has been widely spared across the globe. In the top 20 […]Read More

Anaeropharma Science and Astellas Pharma Collaborates to Develop Novel Anti-Tumor

Shots: Collaboration is for development of novel drugs utilizing B. longum as a drug delivery carrier for in-situ Delivery and Production System (i-DPS) Technology. Astellas has option rights to further develop and commercialize the develop product Anaeropharma has developed APS001F, a recombinant Bifidobacterium expresses Cytosine Deaminase which converts a prodrug, 5-FC, to an anti-cancer drug, […]Read More